ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,675Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 1269

$586K Total Retail Price of All Prescriptions

Rank: 99 out of 1269

308 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 308 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 308 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,237 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
SIMVASTATIN 356 295 1 3
AMLODIPINE BESYLATE 349 332 2 2
ALENDRONATE SODIUM 245 233 3 28
METFORMIN HCL 212 193 4 9
LEVOTHYROXINE SODIUM 209 162 5 4
FUROSEMIDE 204 160 6 5
WARFARIN SODIUM 174 139 7 12
TAMSULOSIN HCL 173 172 8 31
LISINOPRIL 161 128 9 1
METOPROLOL TARTRATE 160 135 10 6
LOSARTAN POTASSIUM 138 129 11 15
OMEPRAZOLE 133 115 12 8
LANTUS 114 90 13 39
RISPERIDONE 114 89 13 43
PRAVASTATIN SODIUM 113 78 15 11
MELOXICAM 109 94 16 68
AZITHROMYCIN 107 96 17 42
ESCITALOPRAM OXALATE 106 83 18 58
ATENOLOL 103 97 19 14
DIOVAN 102 89 20 35
ATORVASTATIN CALCIUM 100 94 21 7
TRICOR 92 80 22 152
LIDODERM 90 82 23 56
METOPROLOL SUCCINATE 90 88 23 13
CLOPIDOGREL 85 78 25 32
GABAPENTIN 83 51 26 17
ZOLPIDEM TARTRATE 82 80 27 19
TRAMADOL HCL 81 37 28 16
SERTRALINE HCL 77 54 29 23
CARVEDILOL 75 62 30 29
HYDROCHLOROTHIAZIDE 71 54 31 10
HYDRALAZINE HCL 67 41 32 48
LEVETIRACETAM 66 34 33 55
PLAVIX 63 59 34 47
RANITIDINE HCL 61 50 35 27
RISPERIDONE ODT 60 40 36 357
FINASTERIDE 59 59 37 112
CIPROFLOXACIN HCL 56 52 38 66
AMOXICILLIN 52 47 39 129
QUETIAPINE FUMARATE 52 39 39 53
OLANZAPINE 52 40 39 89
DONEPEZIL HCL 52 52 39 22
LOSARTAN-HYDROCHLOROTHIAZIDE 51 50 43 59
SANTYL 50 48 44 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.